{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:40:27Z","timestamp":1770914427699,"version":"3.50.1"},"reference-count":117,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2019,8,8]]},"DOI":"10.1080\/02791072.2019.1597224","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:56:40Z","timestamp":1554771400000},"page":"311-322","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users"],"prefix":"10.1080","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8352-3688","authenticated-orcid":false,"given":"Kirsten E.","family":"Smith","sequence":"first","affiliation":[{"name":"Kent School of Social Work, University of Louisville","place":["Louisville, USA"]},{"name":"Center on Drug and Alcohol Research, University of Kentucky","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Bunting","sequence":"additional","affiliation":[{"name":"Department of Sociology, University of Kentucky","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Walker","sequence":"additional","affiliation":[{"name":"Center on Drug and Alcohol Research, University of Kentucky","place":["Lexington, USA"]},{"name":"Department of Behavioral Science, University of Kentucky","place":["Lexington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0923-4554","authenticated-orcid":false,"given":"Martin T.","family":"Hall","sequence":"additional","affiliation":[{"name":"Kent School of Social Work, University of Louisville","place":["Louisville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-8949","authenticated-orcid":false,"given":"Oliver","family":"Grundmann","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida","place":["Gainesville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Castillo","sequence":"additional","affiliation":[{"name":"University of Miami School of Law, University of Miami","place":["Coral Gables, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/156802611795371305"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2012.03.009"},{"key":"e_1_3_3_4_1","unstructured":"American Kratom Association. 2019. Home. https:\/\/www.americankratom.org\/ (accessed\u00a0February\u00a05 \u00a02019)."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6529a4"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078345816634079"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701205869"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2018.02.010"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02209.x"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020262"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.02.024"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2017.03.020"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.023"},{"key":"e_1_3_3_14_1","first-page":"972","article-title":"Kratom crackdown: How the DEA abused its emergency scheduling authority under the Controlled Substances Act","volume":"72","author":"Castillo O.","year":"2018","unstructured":"Castillo, O. 2018. Kratom crackdown: How the DEA abused its emergency scheduling authority under the Controlled Substances Act. University of Miami Law Review 72:972\u20131024.","journal-title":"University of Miami Law Review"},{"key":"e_1_3_3_15_1","unstructured":"Centers for Disease Control and Prevention. 2017a. Annual surveillance report of drug-related risks and outcomes \u2014 United States 2017. Surveillance special report 1. Centers for disease control and prevention U.S. department of health and human services. Accessed April 1 2018. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2017cdc-drug-surveillance-report.pdf."},{"key":"e_1_3_3_16_1","unstructured":"Centers for Disease Control and Prevention. 2017b. Drug overdose death data | Drug overdose | CDC injury center. Accessed April 11 2018. https:\/\/www.cdc.gov\/drugoverdose\/data\/statedeaths.html."},{"key":"e_1_3_3_17_1","volume-title":"Quality improvement and care coordination: Implementing the CDC guideline for prescribing opioids for chronic pain","author":"Centers for Disease Control and Prevention","year":"2018","unstructured":"Centers for Disease Control and Prevention. 2018. Quality improvement and care coordination: Implementing the CDC guideline for prescribing opioids for chronic pain. Atlanta, GA: National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2017.1.E195"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.09.007"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508490"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.09.029"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00028-3"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2011.640732"},{"key":"e_1_3_3_25_1","unstructured":"Department of Justice. 2016. Memorandum: Department of justice strategy to combat opioid epidemic. https:\/\/www.justice.gov\/opioidawareness\/file\/896776\/download."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.17711\/SM.0185-3325.2017.010"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2016.12.020"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00014"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.06.002"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2017.08.066"},{"key":"e_1_3_3_31_1","unstructured":"Federal Register: The Daily Journal of the United States Government. 2016 October 13. Withdrawal of notice of intent to temporarily place mitragynine and 7-hydroxymitragynine into schedule I. https:\/\/www.federalregister.gov\/documents\/2016\/10\/13\/2016-24659\/withdrawal-of-notice-of-intent-to-temporarily-place-mitragynine-and-7-hydroxymitragynine-into."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00297"},{"key":"e_1_3_3_33_1","unstructured":"Food and Drug Administration (FDA). 2018a. FDA and kratom [Internet]. US food and drug administration home page. https:\/\/www.fda.gov\/NewsEvents\/PublicHealthFocus\/ucm584952.htm."},{"key":"e_1_3_3_34_1","unstructured":"Food and Drug Administration (FDA). 2018b. Statement from FDA Commissioner Scott Gottlieb M.D. on the agency\u2019s scientific evidence on the presence of opioid compounds in kratom underscoring its potential for abuse [Internet]. US Food and Drug Administration Home Page. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm595622.htm."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-014-0023-0"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2014.950030"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12103-013-9224-4"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2016.1229876"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2017.1371363"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.03.007"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14371"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2013.805761"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-8490.159580"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.11.012"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.018"},{"key":"e_1_3_3_46_1","volume-title":"Drug overdose deaths in the United States, 1999\u20132016","author":"Hedegaard H.","year":"2017","unstructured":"Hedegaard, H., M. Warner, and A. M. Mini\u00f1o. 2017. Drug overdose deaths in the United States, 1999\u20132016. NCHS Data Rief, No 294, National Center for Health Statistics, Hyattsville, MD."},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12639"},{"key":"e_1_3_3_48_1","first-page":"1","article-title":"The abuse potential of kratom according the 8 factors of the controlled substances act: Implications for regulation and research","author":"Henningfield J. E.","year":"2018","unstructured":"Henningfield, J. E., R. V. Fant, and D. W. Wang. 2018. The abuse potential of kratom according the 8 factors of the controlled substances act: Implications for regulation and research. Psychopharmacology 235:1\u201317.","journal-title":"Psychopharmacology"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12385"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1184"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14180"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2017.120305"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.960109"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2011.12.053"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12260"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2015.1037521"},{"key":"e_1_3_3_57_1","unstructured":"Kentucky Cabinet for Health and Family Services. 2018. Kentucky all schedule prescription electronic reporting - cabinet for health and family services. https:\/\/chfs.ky.gov\/agencies\/os\/oig\/dai\/deppb\/Pages\/kasper.aspx."},{"key":"e_1_3_3_58_1","unstructured":"Kentucky Department of Corrections. 2018. Substance abuse treatment modalities - department of corrections. https:\/\/corrections.ky.gov\/Divisions\/sap\/Pages\/modalities.aspx."},{"key":"e_1_3_3_59_1","unstructured":"Kentucky Office of Drug Control Policy. 2016. 2016 overdose fatality report. https:\/\/odcp.ky.gov\/Documents\/2016%20ODCP%20Overdose%20Fatality%20Report%20Final.pdf."},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S85951"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.4.242"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.08.026"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.08.317"},{"key":"e_1_3_3_65_1","first-page":"1","article-title":"Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey","author":"Likhitsathian S.","year":"2018","unstructured":"Likhitsathian, S., W. Jiraporncharoen, A. Aramrattana, C. Angkurawaranon, M. Srisurapanont, K. Thaikla, and R. Jarubenja. 2018. Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey. Journal of Substance Use 23:1\u20136.","journal-title":"Journal of Substance Use"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.08.032"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.05.025"},{"key":"e_1_3_3_68_1","article-title":"Trends and patterns of opioid analgesic prescribing: Regional and Rural-urban variations in Kentucky from 2012 to 2015","author":"Luu H.","year":"2018","unstructured":"Luu, H., S. Slavova, P. R. Freeman, M. Lofwall, S. Browning, and H. Bush. 2018. Trends and patterns of opioid analgesic prescribing: Regional and Rural-urban variations in Kentucky from 2012 to 2015. The Journal of Rural Health35:97\u2013107.","journal-title":"The Journal of Rural Health35:97\u2013107."},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-016-0588-y"},{"key":"e_1_3_3_70_1","first-page":"3","article-title":"Intravenous kratom use in a patient with opioid dependence","volume":"1","author":"Lydecker A. G.","year":"2017","unstructured":"Lydecker, A. G., M. D. Zuckkerman, J. B. Hack, B. Becker, J. K. Cherkes, E. W. Boyer, and K. M. Babu. 2017. Intravenous kratom use in a patient with opioid dependence. Journal of Toxicology and Pharmacology 1:3.","journal-title":"Journal of Toxicology and Pharmacology"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1050"},{"key":"e_1_3_3_72_1","first-page":"e359","article-title":"Overprescribing is major contributor to opioid crisis","author":"Makary M. A.","year":"2017","unstructured":"Makary, M. A., H. N. Overton, and P. Wang. 2017. Overprescribing is major contributor to opioid crisis. BMJ e359.","journal-title":"BMJ"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19112"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.029"},{"key":"e_1_3_3_75_1","volume-title":"Pharmacological studies on 7-Hydroxymitragynine, isolated from the Thai herbal medicine Mitragyna speciosa: Discovery of an orally active opioid analgesic","author":"Matsumoto K.","year":"2006","unstructured":"Matsumoto, K. 2006. Pharmacological studies on 7-Hydroxymitragynine, isolated from the Thai herbal medicine Mitragyna speciosa: Discovery of an orally active opioid analgesic. Tokyo: Department of Molecular Pharmacology and Pharmacotherapeutics, Graduate School of Pharmaceutical Sciences, Chiba University."},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00714-5"},{"key":"e_1_3_3_77_1","first-page":"359:j4730","article-title":"How inappropriate prescribing prompted the opioid addiction ravaging small town America","author":"McCarthy M.","year":"2017","unstructured":"McCarthy, M. 2017. How inappropriate prescribing prompted the opioid addiction ravaging small town America. BMJ 359:j4730.","journal-title":"BMJ"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.02990.x"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1037\/rmh0000064"},{"key":"e_1_3_3_80_1","unstructured":"National Institutes of Health. 2018 July 5. In the news: Kratom (Mitragyna speciosa). https:\/\/nccih.nih.gov\/news\/kratom."},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0079-5"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/pam.22049"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S24800"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.240622"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-65361-7_3"},{"key":"e_1_3_3_86_1","first-page":"792","article-title":"Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck W. C.","year":"2012","unstructured":"Prozialeck, W. C., J. K. Jivan, and S. V. Andurkar. 2012. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. The Journal of the American Osteopathic Association 112:792\u201399.","journal-title":"The Journal of the American Osteopathic Association"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2012.09.004"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2016.1156791"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2015.1012610"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2017.12.017"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.05.004"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.v32.3"},{"key":"e_1_3_3_93_1","first-page":"1","article-title":"Severity of kratom (Mitragyna speciosa Korth.) psychological withdrawal symptoms","author":"Singh D.","year":"2018","unstructured":"Singh, D., S. Narayanan, C. P. M\u00fcller, M. T. Swogger, A. A. Rahim, M. F. I. Leong Bin Abdullah, and B. K. Vicknasingam. 2018c. Severity of kratom (Mitragyna speciosa Korth.) psychological withdrawal symptoms. Journal of Psychoactive Drugs 50:1\u20136.","journal-title":"Journal of Psychoactive Drugs"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2018.04.005"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.051"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-017-0185-7"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002871"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.034"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12256"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/19371918.2015.1021024"},{"key":"e_1_3_3_101_1","unstructured":"Substance Abuse Mental Health Services Administration. 2018. Buprenorphine treatment practitioner locator | SAMHSA - Substance Abuse and Mental Health Services Administration. Accessed October 12 2018. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/physician-program-data\/treatment-physician-locator."},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.03.015"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2015.1096434"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm010576e"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.1908849"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebcr.2018.04.002"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2018.1468693"},{"key":"e_1_3_3_108_1","unstructured":"U.S. Department of Agriculture. 2013. Measuring rurality: Rural-urban continuum codes. United States Department of Agriculture Economic Research Service website https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes\/documentation\/."},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.12.003"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2018.1461876"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0362-3"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-015-1279-y"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1080\/01639625.2016.1197034"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V35N7p487"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2012.0098"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)90119-8"},{"key":"e_1_3_3_118_1","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged\u2264 30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"Zibbell J. E.","year":"2015","unstructured":"Zibbell, J. E., K. Iqbal, R. C. Patel, A. Suryaprasad, K. J. Sanders, L. Moore-Moravian, and D. Holtzman. 2015. Increases in hepatitis C virus infection related to injection drug use among persons aged\u2264 30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012. Morbidity Mortality Weekly Report 64:453\u201358.","journal-title":"Morbidity Mortality Weekly Report"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2019.1597224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:55:53Z","timestamp":1770911753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2019.1597224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8,8]]}},"alternative-id":["10.1080\/02791072.2019.1597224"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2019.1597224","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}